Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Linking Gut Microbiota to Colorectal Cancer
Hans Raskov, Jakob Burcharth, Hans‐Christian Pommergaard
Journal of Cancer (2017) Vol. 8, Iss. 17, pp. 3378-3395
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer
Huawei Zeng, Shahid Umar, Bret Rust, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1214-1214
Open Access | Times Cited: 364
The microbiome and gynaecological cancer development, prevention and therapy
Paweł Łaniewski, Zehra Esra Ilhan, Melissa M. Herbst‐Kralovetz
Nature Reviews Urology (2020) Vol. 17, Iss. 4, pp. 232-250
Open Access | Times Cited: 291
Role of microbiota-derived short-chain fatty acids in cancer development and prevention
Rasoul Mirzaei, Azam Afaghi, Sajad Babakhani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111619-111619
Open Access | Times Cited: 291
Gut microbiome, big data and machine learning to promote precision medicine for cancer
Giovanni Cammarota, Gianluca Ianiro, Anna M. Ahern, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 635-648
Closed Access | Times Cited: 241
Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
Giovanni Bruno, Piera Zaccari, Giulia Rocco, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 22, pp. 2706-2719
Open Access | Times Cited: 194
Probiotics for cancer alternative prevention and treatment
Tesfaye Legesse Bedada, Tatek Kasim Feto, Kaleab Sebsibe Awoke, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110409-110409
Open Access | Times Cited: 189
The role of bile acids in carcinogenesis
Tadeja Režen, Damjana Rozman, Tündé Kovàcs, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 173
Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India
Ankit Gupta, Darshan B. Dhakan, Abhijit Maji, et al.
mSystems (2019) Vol. 4, Iss. 6
Open Access | Times Cited: 167
The promise of the gut microbiome as part of individualized treatment strategies
Daniel Schupack, Ruben A. T. Mars, Dayne Voelker, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 7-25
Open Access | Times Cited: 110
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis
Taylor M. Halsey, Anusha Shirwaikar Thomas, Tomo Hayase, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 700
Closed Access | Times Cited: 63
Short-chain fatty acids in cancer pathogenesis
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 677-698
Open Access | Times Cited: 47
Significance of Streptococcus gallolyticus subsp. gallolyticus Association With Colorectal Cancer
Ewa Pasquereau-Kotula, Mariana Martins, Laetitia Aymeric, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 132
Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer
Xiaoyan Fan, Yuelei Jin, Guang Chen, et al.
Digestion (2020) Vol. 102, Iss. 4, pp. 508-515
Open Access | Times Cited: 120
Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice
Li Lü, Xiaofei Li, Weilong Zhong, et al.
EBioMedicine (2019) Vol. 48, pp. 301-315
Open Access | Times Cited: 111
The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It
Heather Armstrong, Michael Bording‐Jorgensen, Stephanie Dijk, et al.
Cancers (2018) Vol. 10, Iss. 3, pp. 83-83
Open Access | Times Cited: 105
Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy
Ana Montalban‐Arques, Michael Scharl
EBioMedicine (2019) Vol. 48, pp. 648-655
Open Access | Times Cited: 101
Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis
Dongjia Lin, Lisa Yang, Liling Wen, et al.
Mucosal Immunology (2021) Vol. 14, Iss. 6, pp. 1247-1258
Open Access | Times Cited: 100
The Role of Probiotics in Colorectal Cancer Management
Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Chaiyavat Chaiyasut
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 97
Probiotics in the Treatment of Colorectal Cancer
Robert Hendler, Yue Zhang
Medicines (2018) Vol. 5, Iss. 3, pp. 101-101
Open Access | Times Cited: 88
Driver Gene Mutations and Epigenetics in Colorectal Cancer
Hans Raskov, Jacob Hartmann Søby, Jesper T. Troelsen, et al.
Annals of Surgery (2019) Vol. 271, Iss. 1, pp. 75-85
Closed Access | Times Cited: 81
The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight into the Microbiome–Treatment Axis
A. Sami, I. Elimairi, Catherine Stanton, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8061-8061
Open Access | Times Cited: 78
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer
Thyra Löwenmark, Anna Löfgren‐Burström, Carl Zingmark, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 73
The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis
Emanuel Vamanu, Sachchida Nand
Diseases (2021) Vol. 9, Iss. 3, pp. 45-45
Open Access | Times Cited: 69
Modulating the Microbiome for Crohn’s Disease Treatment
Rachael Gowen, Ahmed Gamal, Luca Di Martino, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 828-840
Open Access | Times Cited: 25
The inhibition effects of Lentilactobacillus buchneri-derived membrane vesicles on AGS and HT-29 cancer cells by inducing cell apoptosis
Adel Abedi, Farzaneh Tafvizi, Parvaneh Jafari, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top